Table 1.
Effect ILs (IL-2, IL-15, IL-18) toward NK cells viability (%)
| Concentrations (ILs) for inducing NK cells | NK cells viability (%) | |||
|---|---|---|---|---|
| Incubation time (24 h) | Incubation time (48 h) | Incubation time (72 h) | Incubation time (96 h) | |
| Control | ||||
| (non-induced NK) | 100.00±13.16 abA | 100.00±4.17 abA | 100.00±0.46 aA | 100.00±6.15 aA |
| IL2-NK (5 ng/ml) | 104.14±12.49 abA | 109.66±9.12 abcAB | 134.50±16.67 bcBC | 143.13±3.20 bcC |
| IL2-NK (10 ng/ml) | 122.67±9.36 bA | 129.12±0.39 cA | 152.69±11.63 cB | 153.16±4.21 cB |
| IL15-NK (5 ng/ml) | 79.36±12.27 aA | 124.92±0.72 bcB | 138.27±1.14 bcB | 141.88±9.35 bcB |
| IL15-NK (10 ng/ml) | 109.29±23.55 abA | 134.62±5.64 cAB | 140.77±0.44 bcAB | 153.37±1.73 cB |
| IL18-NK (5 ng/ml) | 81.19±17.92 abA | 87.14±8.76 aA | 120.36±6.64 abB | 128.88±5.53 bB |
| IL18-NK (10 ng/ml) | 104.81±11.12 abA | 115.75±21.71 bcAB | 155.28±7.59 cC | 142.31±7259 bcC |
*This research was performed 3 replication for NK cells viability. Data of NK cells viability (%) are presented as mean ±standard deviation, different small letters in the same column (among concentrations of ILs (IL-2, IL-15, IL-18) treatment in each periodic incubations (day 1, 2, 3, 4). Different capital letters in the same row (among periodic incubations in each ILs treatment), were significantly different at p < 0.05 (Tukey honestly significant difference post hoc test)